|
|
|
Universal Detection Technology Profile:
Universal Detection Technology is a revenue generating company with
government, military and commercial contracts in a
very hot sector, anti-terrorism. Past clients
include the U.S. Army & British Gov t. Universal
Detection Technology has
Patented technology that can detect Anthrax. The
technology was developed by NASA & licensed by
Universal Detection Technology |
-----
After the market closed on Tuesday May 6th
-----
Universal
Detection Technology Invited to Present Its BSM-2000
Anthrax Detection Technology at the IEEE
International Conference on Technologies for
Homeland Security!
Having announced
entered into a distribution agreement with Mirion
Technologies Dosimetry Services Division to
distribute the RADView(tm) PD Dosimeter badge,
Universal Detection Technology (OTCBB: UDTT) should
have investors, once again, monitoring the stock
closely. The company, a developer of
early-warning monitoring technologies to protect
people from bioterrorism and other infectious health
threats and provider of counter-terrorism consulting
and training services, issued a press release
yesterday after the markets closed announcing that
it will present the technology for its BSM-2000
airborne anthrax monitor in a poster session at the
IEEE International Conference on Technologies for
Homeland Security. The conference is being held
at the Westin Hotel in Waltham, Massachusetts on May
12-13. |
|
Great news for UDTT!
"The IEEE conference is a great opportunity
to present our technology to industry leaders in
Homeland Security," said Mr. Jacques Tizabi,
UDTT's Chief Executive Officer. "We also look
forward to meeting with representatives from the
DHS present at the conference such as Dr. Thomas
Celluci whose task is to facilitate cooperation
between government and private industry," he
added.

With Technical Assistance from the Department of
Homeland Security, Science & Technology
Directorate, the eighth annual 2008 IEEE
International Conference on Technologies for
Homeland Security (HST 08) focuses on novel and
innovative technologies
addressing pressing national security problems.
The Conference brings together over 300
innovators from leading universities, research
laboratories, Homeland Security Centers of
Excellence, small businesses, system integrators
and the end user community to discuss emerging
technologies in priority areas of interest to
federal and state governments, and fosters
technology commercialization by providing a
forum for networking with government and
business leaders.
Last week, the company also reported it has
entered into a distribution agreement with
Mirion Technologies Dosimetry Services Division
to distribute the RADView(tm) PD Dosimeter
badge. The RADView PD dosimeter badge
from Mirion Technologies is a lightweight,
credit card size radiation dosimeter
incorporating a self-developing radiochromic
film to provide visual measurement of absorbed
radiation dose.
Mirion Technologies is one of the world leaders
in radiation detection, measuring and
monitoring. With over 740 employees
worldwide, Mirion has 14 production facilities
in Europe, Asia, and North America. The
Dosimetry Services Division provides dosimetry,
consulting, and system integration services to
the nuclear, government, and medical markets.
The division is headquartered in Irvine,
California, and sells under the Global Dosimetry
Solutions brand.
Investors are urged to watch the company! |
|
|
|
|
 |

has twice presented its technology to the US
Army Edgewood Chemical Biological Center.
The meetings have paved theway for the Army
Biosensor Team to evaluate potential
collaboration and funding opportunities. ECBC
develops and tests systems to enhance the
ability of military personnel and civilian
emergency responders to detect and identify
chemical/ biologica l warfare agents and
contaminants.
has exclusive commercial rights to Microbial
Event Monitor (MEM). The technology that
will be used in MEM has been developed by NASA s
JPL. The MEM can be designed to monitor the air
for airborne bacteria including the deadly MRSA
(Methicillin-Resistant Staphylococcus Aureus).
The technology is under exclusive license to
from the California Institute of Technology
(Caltech) Office of Technology Transfer and is
protected under a provisional patent.
has expanded the range of products it offers to
include germicides that eliminate MRSA. The
number of MRSA cases havebeen on the rise
throughout in recent years. According to a
recent paper published in the Journal of the
American Medical Association, the MRSA microbe,
a strain of a once harmless staph bacterium that
has become invulnerable to first- line
antibiotics, is responsible for more than 94,000
serious infections and nearly 19,000 deaths each
year. Recent reports also indicate the spread of
MRSA into the nation's schools including a
recent fatal case in a Virginia high school.
UDTT has
supplied its anti-MRSA germicide to national
franchises such as select Quiznos restaurants.
The EPA approved germicide eliminates MRSA on
contact and keeps the are sterile for a period
of 1 week following application.
UDT s
5-agent Detection kits are used by first
responders throughout the country.
The kits are designed to test for anthrax,
Botulinum Ricin, Plague, and SEB s in one rapid
and accurate test. The Washington D.C. Fire
Department & emergency Services & the Burbank
Fire Department are among first responders that
use the 5-agent kits.
Universal Detection Technology Is Partners with NASA-
owns
the license to a patented technology developed
at NASA's JPL and utilized in
's BSM-2000
used for autonomous monitoring of the air for
presence of airborne bacterial spores such as
anthrax.
also supplies detection kits for
detection of up to 5 bioterrorism agents.
Government Contracts Continue To Roll In-
has already provided its anthrax detection kits
to the U.S. Army and sold bacterial spore
detection systems to the Government of the
United Kingdom.
Remarkable Partnerships with Prominent
Organizations-On Feb. 1 2008,
announced
that its BSM-2000 Anthrax Detection System was
posted on the
Responder
Knowledge Base (RKB)
website. This w ebsite, sponsored by the
Department of Homeland Security, is the premier
source for information
on products, standards, certifications, grants
and other equipment-related information needed
by First Responders (agencies charged with
dealing with terrorism events, including
biological and nuclear incidents). The World
Wide Market Potential For
s Anthrax
Detection Technology is Enormous!
Breaking Into The China Market-
also signed an agreement with Kadinuo Science
and Technology Company in Beijing on Jan. 30 to
market and distribute
s products in China.
Kadinuo, a leader in the radiation-detection
field in China, also creates various
decontamination and biohazard technologies for
the Chinese State Environmental Protection
Administration, the Chinese Center for Disease
Control and Prevention, the Administration of
Quality Supervision, the Inspection and
Quarantine Division, and the Public Security
Bureau. In the past two years, Kadinuo has won
13 and 16 government bids respectively.
Universal Detection Technology Comments on the
Threat of Terrorism at the 2008 Olympic Games in
China
read more
Leading the Industry with Superior
Solutions- Aside from large drug companies
developing vaccines to combat terrorism
(specifically bioterrorism), there are few
companies invested in emergency response and
detection of bioterrorism hazards, putting
Universal Detection Technology on the leading
edge of this unexplored frontier. |
|
|
_________________________________________________________________________________ |
 |
|
Presidents
Request
-
Breaking Industry Information issued by U.S.
Department of Homeland Security!!!
Earlier
this month, Assistant Secretary
and Chief
Medical Officer Jeffery Runge, M.D. gave his
testimony before the House Committee on
Appropriations, Subcommittee on Homeland
Security. The testimony outlined several
points, mainly the 2009 budget request for the
Office of Health Affairs (OHA) within the
Department of Homeland Security (DHS). The
following are examples of key gaps now being
addressed by OHA:
-
Biodefense:
There was no principal agent for all the
Department s biodefense activities,
including its obligations under Homeland
Security Presidential Directive-9 (Food and
Agro-Defense) and Homeland Security
Presidential Directive-10 (Biodefense);
-
Contingency
Planning:
The Department had no single point of
responsibility for subject matter
expert-driven end-to-end contingency
planning for bioterrorism and other
catastrophic scenarios involving threats to
the health of the population, from threat
awareness through surveillance and
detection, prevention and protection,
response, and physical, psychological, and
environmental recovery;
-
Occupational
Health and Safety:
The Department had no consistent policies,
metrics or standards for occupational health
issues and operational medical support for
its diverse workforce.
The President is
requesting $161.3
for FY 2009 to further
objectives of the OHA mission. This amount
represents an increase of $44.8
over the
FY 2008 enacted level. OHA s strategic
objectives for FY 2009 include:
-
discharging
the Department s responsibilities for
biodefense;
-
deploying
automated detection equipment for early
warning of a release of an aerosolized
biological agent pending successful
completion of testing and evaluation in FY
2008;
-
enhancing the
security of the Nation s food and
agriculture supply;
-
initiating
activities to increase coordination of
medical readiness across Federal, State,
Tribal and local governments and the private
sector;
-
working across
DHS to protect the health and safety of the
Department s workforce; and
-
providing
medical oversight for the Department s
medical activities.
The following is
one of many programs which highlight how OHA
will utilize its funding to meet these strategic
challenges:
BioWatch-
BioWatch provides a capability for early
detection and warning against biological attacks
in over 30 of our Nation s highest-risk urban
areas through placement of a series of
biological pathogen detectors. Deployment of
such technology is critical to our Nation s
security as the detection of a biological
pathogen, such as aerosolized anthrax, at the
earliest stages of release is critical to
successful treatment of the affected
population. Early detection and warning of a
biological attack is essential for the rapid
identification of the bioagent, which allows
prophylactic treatment and prevention of
casualties, provides forensic evidence to law
enforcement on the source and nature of the
attack, and demonstrates a spatial distribution
of contamination and population exposure. To
date, this vital program has conducted over 3
million air samples without a false alarm, and
has formed v ital partnerships with state and
local public health, laboratory, law
enforcement, and environmental health entities
to further its detection mission. These partnerships have had collateral beneficial
effects for our Nation s biodefense through
cooperation across sectors at the local level.
Early detection is
critical to protecting the health of the
Nation. With anthrax for example, a one day
delay in the post-exposure prophylaxis or
treatment of exposed individuals could result in
many thousands of unnecessary deaths. Early
detection and rapid medical treatment is
therefore essential to protecting the health of
the American people during such an incident of
bioterrorism. |
|
|
 |
|
Universal Detection Technology Working Towards Obtaining a Share of the
Biological Warfare Defense Market! Biowarfare Defense is an
Important Priority!
Universal Detection Technology, Inc.
(OTC BB:
), based in Los Angeles, California, is an early
stage developer of monitoring technologies, including a
bio-terrorism detection device for anthrax, based on technology
developed by the Jet Propulsion Laboratory of NASA.
Currently, the main purpose of the Company is to be a supplier of
CBRN detection equipment. In April 2005,
renamed the device as the
BSM-2000.
is targeting this device for use by all federal,
state, and local governmental bodies and agencies (including the
Postal Service and embassies), as well as the private sector for use
at conventions, sporting events, office buildings, financial
exchanges, private mail rooms, and other venues.
believes the device will be seen as a highly effective, fully
automated, and cost efficient anthrax detection system. To date, the
Company has not recognized any sales or revenues from BSM-2000 in the
U.S. but has recognized revenue from sales of the device in the
United Kingdom.
In a recent interview, the Company s CEO highlighted the
cost-effectiveness of the BSM-2000 and its role as a critical,
integrated early-warning alarm system that can issue detection
alerts in real-time, potentially preventing untold casualties and
loss of life in the event of a biological attack. |
|
|
|